About
Technology
Issues
FAQ
Links
Official Page
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab <i>versus</i> chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.